Reuters logo
BRIEF-PTC Therapeutics reports qtrly net loss per share basic and diluted of $0.82
November 2, 2017 / 8:19 PM / 16 days ago

BRIEF-PTC Therapeutics reports qtrly net loss per share basic and diluted of $0.82

Nov 2 (Reuters) - Ptc Therapeutics Inc:

* Qtrly total revenues $41.9 million versus $22.98 million

* Qtrly net loss per share basic and diluted $0.82

* Q3 earnings per share view $-0.68, revenue view $42.2 million -- Thomson Reuters I/B/E/S

* Increasing 2017 revenue guidance to $160-$185M​

* FY2017 revenue view $173.4 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below